Cellevate is a Swedish biotech company that develops and markets the next generation cell culture systems for cell and gene therapy and novel vaccines biomanufacturing. The core nanotechnology, Cellevat3d® is a game-changing, green and sustainable, deep-tech innovation tailored for the biopharmaceutical industry.

This platform allows for an industrial-scale production of two product portfolios, monofiber microcarriers and cross-linked macrocarriers – with unparalleled surface cell growth, reproducibility, flexibility, and scalability, which ultimately lead to the highest productivity and process economy.

Vision

We provide access to a new dimension of upstream bioprocessing for better, faster and more sustainable biopharmaceuticals at lower cost.

Mission

We are on a mission to reinvent upstream bioprocessing from R&D to large-scale manufacturing, through a single use, sustainable, scalable and versatile nanotechnology platform: Cellevat3d®.

Core values

We are Champions

We are champions of a better way in biopharmaceutical manufacturing, challenging the status quo and legacy technology to lead the way in next dimension upstream bioprocessing.

We are Experts

We are experts, combining cutting-edge expertise in bioprocess engineering with nanotechnology to create an unparalleled product platform: Cellevat3d®.

We strive for a sustainable future

We strive for a more sustainable future by revolutionizing biopharmaceutical manufacturing to reduce costs, increase yields and give everyone the opportunity to live a better, healthier life.

We pursue perfection

We pursue perfection and professionalism in everything we do – from commercial product quality to customer service and research partnerships – to create greater value for our customers now and in the future.